Role of cytokines in the maintenance of the memory immune response induced by a rat histiocytoma in syngeneic hosts

Cytokines, Cellular and Molecular Therapy

Volumn 4, Issue 3, 1998, Pages 169-175

  Nandakumar, K S ^a   Varalakshmi, Ch ^a   Khar, Ashok ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Cytokines; Immune memory; Tumor regression

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ASCITES; CANCER TRANSPLANTATION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CONTROLLED STUDY; HISTIOCYTOMA; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; REMISSION; SPLEEN CELL; TUMOR IMMUNITY;

ANIMALS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HISTIOCYTOMA, BENIGN FIBROUS; IMMUNOLOGIC MEMORY; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RATS; RATS, WISTAR; SKIN NEOPLASMS;

EID: 0031696404     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bruno L, Kirberg J, Von Boehmer H, On the cellular basis of immunological T cell memory. Immunity (1995) 2: 37-43.
2. Beverley PCL, Generation of T-cell memory. Curr Opin Immunol (1996) 8: 327-30.
3. - cytotoxic T lymphocytes J Exp Med (1998) 187: 49-57.
4. Ahmed R, Gray D, Immunological memory and protective immunity: understanding their relation. Science (1996) 272 54-60.
5. Garrido F, Ruiz-Cabello F, Cabrera T et al, Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today (1997) 18: 89-95.
6. Musiani P, Modesti A, Giovarelli M et al, Cytokines, tumor-cell death and immunogenicity: a question of choice. Immunol Today (1997) 18: 32-6.
7. Rosenberg SA, Immunotherapy and gene therapy of cancer. Cancer Res (1991) 51: 5074s-9s.
8. Liu Y, Linsley PS, Costimulation of T cell growth Curr Opin Immunol (1992) 4: 265-70.
9. Tripp CS, Wolf SE, Unanue ER, Interleukin-10 and tumor necrosis factor α are co-stimulators of interferon-γ production by natural killer cells in severe combined immuno-deficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist. Proc Natl Acad Sci USA (1993) 90: 3725-9.
10. Fujimoto S, Greene MI, Sehon AH, Regulation of the immune response to tumor antigens II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol (1976) 116: 800-6.
11. Knar A, Development and characterization of a rat histiocyte-macrophage tumor line. J Natl Cancer Inst (1986) 76: 871-8.
12. Khar A, Characterization of spontaneous immunological regression in a histiocytoma: I. Role of NK cells and antitumor antibodies. Int J Oncol (1993) 2: 393-8.
13. Bright JJ, Kausalya S, Khar A, Natural killer cell activation-associated induction of target cell DNA fragmentation in a spontaneously regressing rat histiocytoma. Immunology (1995) 85: 638-44.
14. Khar A, Pardhasaradhi BVV, Varalakshmi Ch et al, Natural killer cell as the effector which mediates in vivo apoptosis in AK-5 tumor cells. Cell Immunol (1997) 177: 86-92.
15. Kausalya S, Varalakshmi C, Khar A, Correlation of in vitro and in vivo effects of interferon-γ with the spontaneous regression of a rat histiocytoma. J Interferon Cytokine Res (1995) 15: 647-54.
16. Hegde SP, Bright JJ, Kausalya S, Khar A, AK-5 tumor induced expression of IL-12: role of IL-12 in AK-5 regression. Cell Immunol (1995) 162: 241-7.
17. Khar A, Kausalya S, Kamal MA, AK-5 tumor-induced modulation of host immune function: upregulation of Th-1-type cytokine response mediates early tumor regression. Cytokines Mol Ther (1996) 2: 39-46.
18. Khar A, Varalakshmi Ch, Pardhasaradhi BVV, Mubarak Ali A, Generation of cytotoxic monoclonals against AK-5 histiocytoma: conjugation with daunomycin and use in chemotherapy. Cancer Lett (1992) 64: 163-9.
19. Fust G, Kavai M, Szegedi GY et al, Evaluation of different methods for detecting circulating immune complexes. An interlaboratory study. J Immunol Meth (1980) 38: 281-9.
20. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ, Protein measurement with the folin phenol reagent. J Biol Chem (1951) 193: 265-75.
21. Ijsselmuiden OE, Herbrink P, Meddens MJM et al, Optimizing the solid-phase immunofiltration assay: a rapid alternative to immunoassays. J Immunol Meth (1989) 119: 35-43.
22. Smith KA, Cantrell DA, Interleukin-2 regulates its own receptors. Proc Natl Acad Sci USA (1985) 82: 864-8.
23. Ortaldo JR, Mason AT, Gerard JP et al, Effects of natural and recombinant IL-2 on regulation of IFN production and natural kilter activity: lack of involvement of the TAC antigen for these immunoregulatory effects. J Immunol (1984) 133: 779-83.
24. Grimm EA, Mazumder A, Zhang HZ et al, Lymphokine-activated killer cell phenomenon - lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med (1982) 155: 1823-41.
25. Akbar AN, Salmon M, Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today (1997) 18: 72-6.
26. Armant M, Delespesse G, Sarfati M, IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and upregulate bcl-2 expression. Immunology (1995) 85: 331-7.
27. Trinchieri G, Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 13: 251-76.
28. Wigginton JM, Komschlies KL, Back TC et al, Administration of interleukin-12 with pulse interleukin-2 and the rapid and complete eradication of murine renal carcinoma J Natl Cancer Inst (1996) 88: 38-43.
29. Khar A, Muralikrishna K, Varalakshmi Ch, High intratumoral level of cytokines mediates efficient regression of a rat histiocytoma. Clin Exp Immunol (1997) 110: 127-31.
30. Nandakumar KS, Leelakumari A, Khar A, Early expression of interleukin-12, p40 subunit and IFN-γ inhibits regression of AK-5 tumor. Cytokines Cell Mol Ther (1997) 3: 225-32.
31. Lakshmi Rao K, Varalakshmi Ch, Mubarak Ali A, Khar A, Administration of anti-IL-12 antibody in vivo inhibits rejection of a rat histiocytoma and suppresses cytokine response in a tumor-bearing host. Immunology (1997) 92: 381-7.
32. Sundstrom JB, Ansari AA, Comparative study of the role of professional versus semiprofessional and non-professional antigen presenting cells in the rejection of vascularized organ allografts Transplant Immunol (1995) 3: 273-89.
33. Lopez-Botet M, Moretta L, Strominger J, NK-cell receptors and recognition of MHC class I molecules. Immunol Today (1996) 17: 212-14.
34. + T cells. Annu Rev Immunol (1994) 12: 635-73.
35. Robertson MJ, Soifter RJ, Wolf ST et al, Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med (1992) 175: 779-88.
36. Kausalya S, Hegde SP, Bright JJ, Khar A, Mechanism of antibody-dependent natural killer cell-mediated AK-5 tumor cell death Exp Cell Res (1994) 212: 285-90.
37. Zinkernagel RM, Bachmann MF, Kundig TM et al, On immunological memory. Annu Rev Immunol (1996) 14: 333-67.
38. Sprent J, Immunological memory. Curr Opin Immunol (1997) 9: 371-9.
39. Huang AY, Golumbek P, Ahmad Zadeh M et al, Role of bone marrow-derived cells in presenting MHC class I restricted tumor antigens. Science (1994) 264: 961-5.
40. Von Boehmer H, Hafen K, Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells. Nature (1986) 320: 626-8.
41. Muralikrishna T, Begum Z, Swamy ChVB, Khar A, Molecular cloning and characterization of a tumor rejection antigen from a rat histiocytoma, AK-5. DNA Cell Biol (1998) in press.